[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2001260526A1 - A ligand for enhancing oral and cns delivery of biological agents - Google Patents

A ligand for enhancing oral and cns delivery of biological agents

Info

Publication number
AU2001260526A1
AU2001260526A1 AU2001260526A AU6052601A AU2001260526A1 AU 2001260526 A1 AU2001260526 A1 AU 2001260526A1 AU 2001260526 A AU2001260526 A AU 2001260526A AU 6052601 A AU6052601 A AU 6052601A AU 2001260526 A1 AU2001260526 A1 AU 2001260526A1
Authority
AU
Australia
Prior art keywords
ligand
biological agents
cns delivery
enhancing oral
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001260526A
Inventor
Valery Alakhov
Shengmin Li
Grzegorz Pietrzynski
Lioudmila Tchistiakova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Supratek Pharma Inc
Original Assignee
Supratek Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Supratek Pharma Inc filed Critical Supratek Pharma Inc
Publication of AU2001260526A1 publication Critical patent/AU2001260526A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AU2001260526A 2001-05-07 2001-05-07 A ligand for enhancing oral and cns delivery of biological agents Abandoned AU2001260526A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2001/000926 WO2001090139A2 (en) 2001-05-07 2001-05-07 A ligand for enhancing oral and cns delivery of biological agents

Publications (1)

Publication Number Publication Date
AU2001260526A1 true AU2001260526A1 (en) 2001-12-03

Family

ID=11004110

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001260526A Abandoned AU2001260526A1 (en) 2001-05-07 2001-05-07 A ligand for enhancing oral and cns delivery of biological agents

Country Status (5)

Country Link
EP (1) EP1385873A2 (en)
JP (1) JP2004514410A (en)
AU (1) AU2001260526A1 (en)
CA (1) CA2408387A1 (en)
WO (1) WO2001090139A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7723296B2 (en) 2001-01-18 2010-05-25 Genzyme Corporation Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof
FR2830016B1 (en) * 2001-09-27 2004-06-25 Synt Em COMPOSITIONS FOR THE VECTORIZATION OF TAXOID DERIVATIVES THROUGH THE HEMATOENCEPHALIC BARRIER AND THEIR USE FOR THE TREATMENT OF CANCERS, PARTICULARLY BRAIN CANCERS
JP5137814B2 (en) 2005-04-06 2013-02-06 ジェンザイム・コーポレーション Conjugation of PEG and polysialicosomal enzymes via acid labile linkers for therapeutic targeting
EP4293112A3 (en) 2007-01-18 2024-03-13 Genzyme Corporation Oligosaccharides comprising an aminooxy group and conjugates thereof
EP3608330B1 (en) 2008-12-16 2022-11-09 Genzyme Corporation Synthetic intermediates for preparing oligosaccharide-protein conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0599303A3 (en) * 1992-11-27 1998-07-29 Takeda Chemical Industries, Ltd. Peptide conjugate
US6635623B1 (en) * 1997-06-13 2003-10-21 Baylor College Of Medicine Lipoproteins as nucleic acid vectors
US6015787A (en) * 1997-11-04 2000-01-18 New England Medical Center Hospitals, Inc. Cell-permeable protein inhibitors of calpain

Also Published As

Publication number Publication date
WO2001090139A2 (en) 2001-11-29
WO2001090139A3 (en) 2002-06-20
CA2408387A1 (en) 2001-11-29
EP1385873A2 (en) 2004-02-04
JP2004514410A (en) 2004-05-20

Similar Documents

Publication Publication Date Title
EP1391212A4 (en) Oral preparations and supports for oral preparations
EP1441661A4 (en) Method and tools for oral hygiene
AU2002349705A1 (en) Azole compound and medicinal use thereof
AU2002339993A1 (en) P-amidobenzylethers in drug delivery agents
AU2002305712A1 (en) Well for processing and filtering a fluid
EP1383518A4 (en) Oral delivery of macromolecules
HK1068812A1 (en) Drug preparations
AU2002323180A1 (en) Hydroxypyridonate and hydroxypyrimidinone chelating agents
EP1466982A4 (en) Pyroglutamyl peptidase and its gene
IL159886A0 (en) Oral antidiabetic agents
AU2002354410A1 (en) Triazole compound and medicinal use thereof
AU2002352410A1 (en) Improved oral medicine dispenser
EP1459726A4 (en) Adhesives for dental use
AU2001260526A1 (en) A ligand for enhancing oral and cns delivery of biological agents
AU2002240942A1 (en) Improved delivery of benefit agents
EP1379228A4 (en) (z)-styrylbenzylsulfones and pharmaceutical uses thereof
EP1465907A4 (en) Modular peptide-based reagent
AU2002308649A1 (en) Compositions and methods for enhancing drug delivery
AU2001263248A1 (en) Fluorescent agent for the identification of tooth dentin
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
GB0128138D0 (en) Pharmaceutical use
AU2002326327A1 (en) Pharmaceutical formulations and ligands for use therein; mimetics for uea-1
AU2002347646A1 (en) Mini-brush for interdental cleaning and care
AU2002337430A1 (en) Functional powders for oral delivery
GB0124009D0 (en) Particles for use in a pharmaceutical composition